Zhen Yu, Ruiye Chen, Peng Gui, Wei Wang, Imran Razzak, Hamid Alinejad-Rokny, Xiaomin Zeng, Xianwen Shang, Lei Zhang, Xiaohong Yang, Honghua Yu, Wenyong Huang, Huimin Lu, Peter van Wijngaarden, Mingguang He, Zhuoting Zhu, Zongyuan Ge
{"title":"基于纵向预训练和标签分布学习的视网膜衰老生物标志物的跨群体研究","authors":"Zhen Yu, Ruiye Chen, Peng Gui, Wei Wang, Imran Razzak, Hamid Alinejad-Rokny, Xiaomin Zeng, Xianwen Shang, Lei Zhang, Xiaohong Yang, Honghua Yu, Wenyong Huang, Huimin Lu, Peter van Wijngaarden, Mingguang He, Zhuoting Zhu, Zongyuan Ge","doi":"10.1038/s41746-025-01751-7","DOIUrl":null,"url":null,"abstract":"<p>Retinal age has emerged as a promising biomarker of aging, offering a non-invasive and accessible assessment tool. We developed a deep learning model to estimate retinal age with enhanced accuracy, leveraging retinal images from diverse populations. Our approach integrates self-supervised learning to capture chronological information from both snapshot and sequential images, alongside a progressive label distribution learning module to model biological aging variability. Trained and validated on healthy cohorts (34,433 participants from the UK Biobank and three Chinese cohorts), the model achieved a mean absolute error of 2.79 years, surpassing previous methods. When applied to broader populations, analysis of the retinal age gap—the difference between retina-predicted and chronological age—revealed associations with increased risks of all-cause mortality and multiple age-related diseases. These findings highlight the potential of retinal age as a reliable biomarker for predicting survival and aging outcomes, supporting targeted risk management and precision health interventions.</p>","PeriodicalId":19349,"journal":{"name":"NPJ Digital Medicine","volume":"11 1","pages":""},"PeriodicalIF":15.1000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A cross population study of retinal aging biomarkers with longitudinal pre-training and label distribution learning\",\"authors\":\"Zhen Yu, Ruiye Chen, Peng Gui, Wei Wang, Imran Razzak, Hamid Alinejad-Rokny, Xiaomin Zeng, Xianwen Shang, Lei Zhang, Xiaohong Yang, Honghua Yu, Wenyong Huang, Huimin Lu, Peter van Wijngaarden, Mingguang He, Zhuoting Zhu, Zongyuan Ge\",\"doi\":\"10.1038/s41746-025-01751-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Retinal age has emerged as a promising biomarker of aging, offering a non-invasive and accessible assessment tool. We developed a deep learning model to estimate retinal age with enhanced accuracy, leveraging retinal images from diverse populations. Our approach integrates self-supervised learning to capture chronological information from both snapshot and sequential images, alongside a progressive label distribution learning module to model biological aging variability. Trained and validated on healthy cohorts (34,433 participants from the UK Biobank and three Chinese cohorts), the model achieved a mean absolute error of 2.79 years, surpassing previous methods. When applied to broader populations, analysis of the retinal age gap—the difference between retina-predicted and chronological age—revealed associations with increased risks of all-cause mortality and multiple age-related diseases. These findings highlight the potential of retinal age as a reliable biomarker for predicting survival and aging outcomes, supporting targeted risk management and precision health interventions.</p>\",\"PeriodicalId\":19349,\"journal\":{\"name\":\"NPJ Digital Medicine\",\"volume\":\"11 1\",\"pages\":\"\"},\"PeriodicalIF\":15.1000,\"publicationDate\":\"2025-06-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NPJ Digital Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41746-025-01751-7\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Digital Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41746-025-01751-7","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
A cross population study of retinal aging biomarkers with longitudinal pre-training and label distribution learning
Retinal age has emerged as a promising biomarker of aging, offering a non-invasive and accessible assessment tool. We developed a deep learning model to estimate retinal age with enhanced accuracy, leveraging retinal images from diverse populations. Our approach integrates self-supervised learning to capture chronological information from both snapshot and sequential images, alongside a progressive label distribution learning module to model biological aging variability. Trained and validated on healthy cohorts (34,433 participants from the UK Biobank and three Chinese cohorts), the model achieved a mean absolute error of 2.79 years, surpassing previous methods. When applied to broader populations, analysis of the retinal age gap—the difference between retina-predicted and chronological age—revealed associations with increased risks of all-cause mortality and multiple age-related diseases. These findings highlight the potential of retinal age as a reliable biomarker for predicting survival and aging outcomes, supporting targeted risk management and precision health interventions.
期刊介绍:
npj Digital Medicine is an online open-access journal that focuses on publishing peer-reviewed research in the field of digital medicine. The journal covers various aspects of digital medicine, including the application and implementation of digital and mobile technologies in clinical settings, virtual healthcare, and the use of artificial intelligence and informatics.
The primary goal of the journal is to support innovation and the advancement of healthcare through the integration of new digital and mobile technologies. When determining if a manuscript is suitable for publication, the journal considers four important criteria: novelty, clinical relevance, scientific rigor, and digital innovation.